Characteristics of 90 patients with NSCLC
| Characteristics . | . | |
|---|---|---|
| Age (y) | ||
| Median | 67 | |
| Range | 30-86 | |
| Sex (%) | ||
| Female | 27 (30.0) | |
| Male | 63 (70.0) | |
| Performance status, n (%) | ||
| 0 | 55 (61.1) | |
| 1 | 22 (24.5) | |
| 2 | 4 (4.4) | |
| 3 | 6 (6.7) | |
| 4 | 3 (3.3) | |
| Stage (%) | ||
| I | 17 (18.8) | |
| II | 5 (5.6) | |
| IIIA | 5 (5.6) | |
| IIIB | 23 (25.6) | |
| IV | 40 (44.4) | |
| Histologic type (%) | ||
| Adenocarcinoma | 64 (71.1) | |
| Squamous cell carcinoma | 23 (25.6) | |
| Adenosquamous cell carcinoma | 1 (1.1) | |
| Large cell carcinoma | 2 (2.2) | |
| Serum CEA (%) | ||
| Normal | 41 (45.6) | |
| More than normal | 49 (54.4) | |
| Characteristics . | . | |
|---|---|---|
| Age (y) | ||
| Median | 67 | |
| Range | 30-86 | |
| Sex (%) | ||
| Female | 27 (30.0) | |
| Male | 63 (70.0) | |
| Performance status, n (%) | ||
| 0 | 55 (61.1) | |
| 1 | 22 (24.5) | |
| 2 | 4 (4.4) | |
| 3 | 6 (6.7) | |
| 4 | 3 (3.3) | |
| Stage (%) | ||
| I | 17 (18.8) | |
| II | 5 (5.6) | |
| IIIA | 5 (5.6) | |
| IIIB | 23 (25.6) | |
| IV | 40 (44.4) | |
| Histologic type (%) | ||
| Adenocarcinoma | 64 (71.1) | |
| Squamous cell carcinoma | 23 (25.6) | |
| Adenosquamous cell carcinoma | 1 (1.1) | |
| Large cell carcinoma | 2 (2.2) | |
| Serum CEA (%) | ||
| Normal | 41 (45.6) | |
| More than normal | 49 (54.4) | |
Abbreviation: CEA, carcinoembryonic antigen.